Christopher M. Rubino
Institute for Clinical Pharmacodynamics
Ordway Research Institute
Inc., Albany
New York
USA
Name/email consistency: high
- Oritavancin population pharmacokinetics in healthy subjects and patients with complicated skin and skin structure infections or bacteremia. Rubino, C.M., Van Wart, S.A., Bhavnani, S.M., Ambrose, P.G., McCollam, J.S., Forrest, A. Antimicrob. Agents Chemother. (2009)
- Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults. Rubino, C.M., Bhavnani, S.M., Ambrose, P.G., Forrest, A., Loutit, J.S. Pulm. Pharmacol. Ther (2009)
- Population pharmacokinetic model for gatifloxacin in pediatric patients. Rubino, C.M., Capparelli, E.V., Bradley, J.S., Blumer, J.L., Kearns, G.L., Reed, M., Jacobs, R.F., Cirincione, B., Grasela, D.M. Antimicrob. Agents Chemother. (2007)
- Pharmacokinetics and pharmacodynamics of gatifloxacin in children with recurrent otitis media: application of sparse sampling in clinical development. Rubino, C.M., Ambrose, P., Cirincione, B., Arguedas, A., Sher, L., Lopez, E., Sáez-Llorens, X., Grasela, D.M. Diagn. Microbiol. Infect. Dis. (2007)
- Optimizing therapy with antibacterial agents: use of pharmacokinetic-pharmacodynamic principles in pediatrics. Rubino, C.M., Bradley, J.S. Paediatr. Drugs (2007)